U.S. markets close in 19 minutes

ADC Therapeutics SA (ADCT)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
23.19+0.13 (+0.56%)
As of 3:41PM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 6/13/2021
Current
3/31/202112/31/20209/30/20206/30/2020
Market Cap (intraday) 5
1.70B1.87B2.46B2.33B3.31B
Enterprise Value 3
1.42B1.55B2.07B2.13B3.20B
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
1.12kN/AN/AN/A1.08k
Price/Book (mrq)
5.725.586.5312.8929.78
Enterprise Value/Revenue 3
1.23kN/AN/AN/AN/A
Enterprise Value/EBITDA 7
-5.80-31.71-39.19-119.08-25.58

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-41.02%
S&P500 52-Week Change 336.39%
52 Week High 356.59
52 Week Low 320.01
50-Day Moving Average 322.32
200-Day Moving Average 327.64

Share Statistics

Avg Vol (3 month) 3398.51k
Avg Vol (10 day) 3336.46k
Shares Outstanding 578.27M
Implied Shares Outstanding 6N/A
Float 29.68M
% Held by Insiders 148.05%
% Held by Institutions 143.33%
Shares Short (May 27, 2021) 47.15M
Short Ratio (May 27, 2021) 424.79
Short % of Float (May 27, 2021) 424.18%
Short % of Shares Outstanding (May 27, 2021) 49.32%
Shares Short (prior month Apr 29, 2021) 47.01M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)-124.33%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-141.82M
EBITDA -245.01M
Net Income Avi to Common (ttm)-254.34M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)383.12M
Total Cash Per Share (mrq)4.99
Total Debt (mrq)47.8M
Total Debt/Equity (mrq)16.04
Current Ratio (mrq)9.50
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-191.78M
Levered Free Cash Flow (ttm)N/A